The role of transketolase in the immunotherapy and prognosis of hepatocellular carcinoma: a multi-omics approach
Our findings suggest that TKT may play a role in tumor immunity and prognosis in HCC. Although these results provide insights into the potential involvement of TKT in immune cell infiltration and survival outcomes, further studies are required to fully elucidate its role in immunotherapy.
Authors
- Rui Mu (ORCID: https://orcid.org/0000-0002-3874-9223)
- Xuan-Yu Gu
- Jiali Yang (ORCID: https://orcid.org/0009-0008-3911-5549)
- Lijin Zhao (ORCID: https://orcid.org/0000-0002-7741-5074)
- Jin Gu (ORCID: https://orcid.org/0000-0001-6277-9062)
- Zheng‐Jun Zhou (ORCID: https://orcid.org/0000-0003-4875-6838)
- Hua Yao (ORCID: https://orcid.org/0000-0003-3033-803X)
Institutions
- Zunyi Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-31
- DOI
- https://doi.org/10.3389/fimmu.2025.1529029
- Citations
- 2
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guizhou Province